Ascorbic acid derivatives or salts thereof, compositions containing such ascorbic acid derivatives or salts thereof, and cosmetics containing such substances.

By synthesizing novel ascorbic acid derivatives or their salts, the problems of insufficient time stability and moisturizing effect of ascorbic acid derivatives in cosmetics have been solved, achieving a superior moisturizing effect and making them suitable for application in cosmetics.

CN123125201APending Publication Date: 2026-11-17SEIWA KASEI CO JP
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202580028928.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-10-17
Filing Date
2025-10-07
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing ascorbic acid derivatives have issues with time stability and efficacy in cosmetics, especially failing to meet higher demands in terms of moisturizing effects.

Method used

By synthesizing a novel ascorbic acid derivative or its salt, specifically by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane, regio-specifically etherifying the hydroxyl groups at the 2- or 3-position, and then subjecting it to acid treatment to introduce diglycerol groups, an ascorbic acid derivative with excellent moisturizing effects is formed.

Benefits of technology

The synthesized ascorbic acid derivatives or their salts exhibit superior moisturizing effects, significantly improving the moisturizing performance of cosmetics when used alone or in combination with other ascorbic acid derivatives compared to conventional ascorbic acid derivatives.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention provides ascorbic acid derivatives or salts thereof with superior moisturizing properties compared to prior art ascorbic acid derivatives, wherein at least one hydrogen atom of the hydroxyl group at the 2 or 3 position of the ascorbic acid is replaced by CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-. This invention also provides ascorbic acid derivative compositions containing said ascorbic acid derivatives or salts thereof and prior art ascorbic acid derivatives, and cosmetics containing said ascorbic acid derivatives or said ascorbic acid derivative compositions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to ascorbic acid derivatives or salts thereof suitable for use as raw materials in cosmetics, compositions containing said ascorbic acid derivatives or salts thereof, and cosmetics containing these substances. Background Technology

[0002] Ascorbic acid is a safe and effective antioxidant, renowned for its excellent skin-brightening properties. However, its instability to light, heat, and oxidation hinders its application in cosmetics. Therefore, various ascorbic acid derivatives or salts thereof with improved time stability compared to ascorbic acid have been proposed. Incorporation into topical skin-brightening preparations (Patent Documents 1 and 2) and into cosmetics (Patent Document 3) has been proposed. However, there is a need for ascorbic acid derivatives with even better time stability and efficacy.

[0003] Against this backdrop, the inventors have proposed ascorbic acid derivatives that exhibit superior time stability and functionality compared to ascorbic acid (Patent Documents 4 and 5). However, further improvements are still needed to enhance the efficacy of these ascorbic acid derivatives.

[0004] [Existing technical documents]

[0005] [Patent Literature]

[0006] [Patent Document 1] JP 1987-221611 A

[0007] [Patent Document 2] JP 2005-060239 A

[0008] [Patent Document 3] JP 1989-228978 A

[0009] [Patent Document 4] JP 4681670 B2

[0010] [Patent Document 5] JP 7267657 B2 Summary of the Invention

[0011] [The problem this invention aims to solve]

[0012] One object of the present invention is to provide ascorbic acid derivatives or salts thereof that have even better moisturizing effects than conventional ascorbic acid derivatives, ascorbic acid derivative compositions containing said ascorbic acid derivatives or salts thereof, and cosmetics containing these substances.

[0013] [Problem-solving methods]

[0014] To address the aforementioned problems, the inventors of this invention conducted in-depth and meticulous research and discovered that novel ascorbic acid derivatives or their salts represented by the following general formula (I) exhibit superior moisturizing effects compared to conventional ascorbic acid derivatives. Furthermore, they found that compositions containing both an ascorbic acid derivative or its salt represented by the following general formula (I) and an ascorbic acid derivative or its salt represented by the following general formula (II) also exhibit superior moisturizing effects compared to conventional ascorbic acid derivatives or their salts alone. This invention was completed based on these findings.

[0015] The first aspect of the present invention is an ascorbic acid derivative or a salt thereof, characterized by being represented by the following general formula (I).

[0016] [Chemical Formula 1]

[0017]

[0018] In equation (I), R 1 and R 2 H, alkyl groups having 1 to 22 carbon atoms, alkenyl groups having 2 to 22 carbon atoms, benzyl groups, R 3 -CH(CH2OH)-、R 3 -CH(OH)-CH2-、R 3 -O-CH2-CH(OH)-CH2- or R 3 -O-CH2-CH(CH2OH)-, where R 3 It is H, an alkyl group having 1 to 22 carbon atoms, or CH2OH-CH(OH)-CH2-, but R 1 and R 2 At least one of them is CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-.

[0019] The salts of ascorbic acid derivatives mentioned above refer to those obtained by substituting cations, such as metal ions or ammonium ions, into formula (I)(R). 1 or R 2 Compounds obtained from ascorbic acid derivatives of H). Salts thereof are also included in this invention.

[0020] Ascorbic acid derivatives or their salts represented by general formula (I) have superior moisturizing effects compared with conventional ascorbic acid derivatives or their salts.

[0021] Where R 1 and / or R 2Ascorbic acid derivatives of general formula (I) with diglycerol group (i.e., CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-) can be obtained by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane to achieve regiospecific etherification at only the 2 and / or 3 positions of the four hydroxyl groups at the 2, 3, 5 and 6 positions of ascorbic acid, followed by acid treatment.

[0022] In addition, R 1 and R 2 Ascorbic acid derivatives consisting entirely of diglycerol groups can be synthesized in a two-step process: first, by introducing a diglycerol group into one of the 2 or 3 positions of the compound through etherification and subsequent acid treatment as described above; then, by further etherification and subsequent acid treatment of the compound to introduce a diglycerol group into another of the 2 or 3 positions.

[0023] Alternatively, they can be synthesized in a one-step process, i.e., by reacting 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxacyclopentane with ascorbic acid in an amount of more than 2 equivalents, followed by acid treatment.

[0024] In the reaction between ascorbic acid and 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane, depending on the etherification reaction conditions, either the 2-position hydroxyl etherification or the 3-position hydroxyl etherification occurs predominantly. When the 2-position hydroxyl etherification occurs predominantly, R can be formed. 2 For R 3 -O-CH2-CH(OH)-CH2- and R 2 For R 3 A mixture of -O-CH2-CH(CH2OH)-. When the hydroxyl group at the 3-position is predominantly etherified, R can be formed. 1 For R 3 -O-CH2-CH(OH)-CH2- and R 1 For R 3 A mixture of -O-CH2-CH(CH2OH)-.

[0025] In ascorbic acid derivatives represented by general formula (I), R of formula (I) 1 or R 2 One of them is R 3 -O-CH2-CH(OH)-CH2- or R 3-O-CH2-CH(CH2OH)- The other being an alkyl group having 1 to 22 carbon atoms, an alkenyl group having 2 to 22 carbon atoms, or a benzyl group can be obtained by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane, followed by acid treatment to obtain R. 1 or R 2 One of them is R 3 -O-CH2-CH(OH)-CH2- or R 3 The compound is obtained by reacting glycidyl, alkyl glycidyl ethers with specific structures, alkenyl glycidyl ethers, phenyl glycidyl ethers, sulfate esters, alkyl halides, benzyl halides, alkenyl halides, etc.

[0026] Alternatively, it can be obtained by reacting ascorbic acid with glycidyl, alkyl glycidyl ethers of a specific structure, alkenyl glycidyl ethers, phenyl glycidyl ethers, sulfates, alkyl halides, benzyl halides, alkenyl halides (these reagents have R... 1 or R 2 The compound was obtained by reacting the compound with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane, followed by acid treatment.

[0027] Furthermore, in ascorbic acid derivatives represented by general formula (I), R in formula (I) 1 and R 2 All are R 3 -O-CH2-CH(OH)-CH2- or R 3 The ascorbic acid derivatives of -O-CH2-CH(CH2OH)- can be synthesized by the two-step or one-step method described above.

[0028] The second aspect of the present invention is a preferred embodiment of the first aspect of the present invention, and is an ascorbic acid derivative or a salt thereof, characterized in that R 1 and R 2 One of them is CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-, while the other is H, an alkyl group having 4 to 18 carbon atoms, CH2(OH)-CH(OH)-CH2-, CH2OH-CH(CH2OH)-, CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-. These compounds are particularly preferred because they exhibit high moisturizing effects.

[0029] A third aspect of the present invention is an ascorbic acid derivative composition comprising an ascorbic acid derivative or a salt thereof represented by general formula (I) and an ascorbic acid derivative or a salt thereof represented by general formula (II), wherein the content of the ascorbic acid derivative or a salt thereof represented by general formula (I) is from 0.1% by mass to 20% by mass of the total amount of the ascorbic acid derivative or a salt thereof represented by general formula (I) and the ascorbic acid derivative or a salt thereof represented by general formula (II). This ascorbic acid derivative composition is preferred because it exhibits superior moisturizing effects compared to conventional ascorbic acid derivatives.

[0030] [Chemical Formula 2]

[0031]

[0032] In this formula, R 4 or R 5 Any one of them is R 6 -O-CH2-CH(OH)-CH2-、R 6 -O-CH2-CH(CH2OH)-、R 6 -CH(CH2OH)- or R 6 -CH(OH)-CH2-, while the other is H, alkyl with 1 to 22 carbon atoms, alkenyl with 2 to 22 carbon atoms, benzyl, R 6 -O-CH2-CH(OH)-CH2-、R 6 -O-CH2-CH(CH2OH)-、R 6 -CH(CH2OH)- or R 6 -CH(OH)-CH2-, where R 6 It is H, an alkyl group having 1 to 22 carbon atoms, an alkenyl group having 2 to 22 carbon atoms, or a phenyl group.

[0033] The ascorbic acid derivatives or salts thereof of the present invention, or compositions containing said ascorbic acid derivatives or salts thereof, can be incorporated into various cosmetics. A fourth aspect of the present invention is a cosmetic, characterized by being formulated with the ascorbic acid derivatives or salts thereof of the first to third aspects of the present invention, or ascorbic acid derivative compositions containing said ascorbic acid derivatives or salts thereof. The fourth aspect of the present invention is a cosmetic with excellent moisturizing properties.

[0034] [Invention Effects]

[0035] The ascorbic acid derivatives or salts thereof represented by general formula (I) of the present invention not only possess the inherent excellent properties of ascorbic acid, but also exhibit superior moisturizing effects compared to conventional ascorbic acid derivatives. Furthermore, compositions combining ascorbic acid derivatives or salts thereof represented by general formula (I) with ascorbic acid derivatives or salts thereof represented by general formula (II) exhibit superior moisturizing effects compared to conventional ascorbic acid derivatives alone. Therefore, by incorporating the ascorbic acid derivatives or salts thereof of the present invention, or compositions of ascorbic acid derivatives containing said ascorbic acid derivatives or salts thereof, into cosmetics, cosmetics with excellent moisturizing effects can be provided. Detailed Implementation

[0036] The following are embodiments for carrying out the present invention, but the scope of the present invention is not limited to the embodiments shown below.

[0037] Specific examples of ascorbic acid derivatives represented by general formula (I) include the compounds listed below, but the scope of the invention is not limited to those compounds.

[0038] In the following embodiments,

[0039] The glycerol group refers to CH2(OH)-CH(OH)-CH2- or CH2(OH)-CH(CH2OH)-, represented by the following general formulas (III) and (IV);

[0040] Diglycerol refers to CH2(OH)-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2(OH)-CH(OH)-CH2-O-CH2-CH(CH2OH)-, represented by the following general formulas (V) and (VI);

[0041] Alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl, ethylhexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecanyl, octadecyl, nonadecanyl, eicosyl, and docosyl, etc.; and

[0042] Alkenyl groups include vinyl, allyl, butenyl, isobutenyl, crotonyl, octenyl, decenyl, dodecenyl, and so on.

[0043] [Chemical Formula 3]

[0044]

[0045] [Chemical Formula 4]

[0046]

[0047] [Chemical Formula 5]

[0048]

[0049] [Chemical Formula 6]

[0050]

[0051] In formulas (III), (IV), (V) and (VI) above, * indicates an ether bond site at position 2 or 3 of ascorbic acid.

[0052] In this invention, glyceryl ascorbic acid refers to a compound in which a glyceryl group is bonded to any one of the plurality of hydroxyl groups of ascorbic acid. Dipolyglyceryl ascorbic acid refers to a compound in which a dipolyglyceryl group (glyceryl-O-glyceryl) is bonded to any one of the plurality of hydroxyl groups of ascorbic acid. The ascorbic acid derivatives of this invention represented by general formula (I) are dipolyglyceryl ascorbic acid in which a dipolyglyceryl group is bonded at the 2-position and / or the 3-position. Specifically, examples include: (1) 2-O-dipolyglyceryl ascorbic acid, (2) 3-O-dipolyglyceryl ascorbic acid, and (3) 2-O-dipolyglyceryl-3-O-dipolyglyceryl ascorbic acid.

[0053] (1) Examples of 2-O-dipolyglycerol ascorbic acid (i.e., 2-O-(glycerol-O-glycerol) ascorbic acid) include 2-O-(glycerol-O-glycerol)-3-O-alkyl ascorbic acid, 2-O-(glycerol-O-glycerol)-3-O-alkenyl ascorbic acid, 2-O-(glycerol-O-glycerol)-3-O-glycerol ascorbic acid and 2-O-(glycerol-O-glycerol)-3-O-benzyl ascorbic acid.

[0054] Examples of 2-O-(glycero-O-glycero)-3-O-alkyl ascorbic acid include 2-O-(glycero-O-glycero)-3-O-ethyl ascorbic acid, 2-O-(glycero-O-glycero)-3-O-butyl ascorbic acid, 2-O-(glycero-O-glycero)-3-O-hexyl ascorbic acid, 2-O-(glycero-O-glycero)-3-O-octyl ascorbic acid, 2-O-(glycero-O-glycero)-3-O-tetradecyl ascorbic acid, and 2-O-(glycero-O-glycero)-3-O-hexadecyl ascorbic acid.

[0055] Examples of 2-O-(glycero-O-glycero)-3-O-enyl ascorbic acid include 2-O-(glycero-O-glycero)-3-O-allyl ascorbic acid, 2-O-(glycero-O-glycero)-3-O-octenyl ascorbic acid, and 2-O-(glycero-O-glycero)-3-O-dodecenyl ascorbic acid.

[0056] (2) Examples of 3-O-dipolyglycerol ascorbic acid (i.e., 3-O-(glycero-O-glycero) ascorbic acid) include 2-O-alkyl-3-O-(glycero-O-glycero) ascorbic acid, 2-O-alken-3-O-(glycero-O-glycero) ascorbic acid, 2-O-glycero-3-O-(glycero-O-glycero) ascorbic acid and 2-O-benzyl-3-O-(glycero-O-glycero) ascorbic acid.

[0057] Examples of 2-O-alkyl-3-O-(glycero-O-glycero)ascorbic acid include 2-O-ethyl-3-O-(glycero-O-glycero)ascorbic acid, 2-O-hexyl-3-O-(glycero-O-glycero)ascorbic acid, 2-O-octyl-3-O-(glycero-O-glycero)ascorbic acid, 2-O-tetradecyl-3-O-(glycero-O-glycero)ascorbic acid, and 2-O-hexadecyl-3-O-(glycero-O-glycero)ascorbic acid.

[0058] Examples of 2-O-alkenyl-3-O-(glycero-O-glycero)ascorbic acid include 2-O-allyl-3-O-(glycero-O-glycero)ascorbic acid, 2-O-octenyl-3-O-(glycero-O-glycero)ascorbic acid, and 2-O-dodecenyl-3-O-(glycero-O-glycero)ascorbic acid.

[0059] (3) 2-O-dipolyglycerol-3-O-dipolyglycerol ascorbic acid (i.e., 2-O-(glycerol-O-glycerol)-3-O-(glycerol-O-glycerol) ascorbic acid) is also included in the ascorbic acid derivatives represented by general formula (I) of the present invention.

[0060] The ascorbic acid derivatives or their salts represented by general formula (I) of the present invention can be prepared by a variety of methods.

[0061] For example, by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxacyclopentane followed by acid treatment, a diglycerol group is introduced onto the oxygen bonded at the 2- or 3-position of ascorbic acid, thereby synthesizing 2-O-(glycero-O-glycero)ascorbic acid or 3-O-(glycero-O-glycero)ascorbic acid. Subsequently, the ascorbic acid derivatives of the present invention can be obtained by alkylating or alkenylating the other oxygen bonded at the 2- or 3-position using known methods.

[0062] Alternatively, the compounds of the present invention can be obtained by first alkylating or alkenylating the oxygen bonded to the 2 or 3 position of ascorbic acid, and then reacting it with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane.

[0063] Furthermore, by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane and then acid-treating it, a diglycerol group is introduced onto the oxygen bonded at the 2- or 3-position of ascorbic acid. Then, a similar reaction is used to introduce the diglycerol group to another site, and the ascorbic acid derivative of the present invention in which diglycerol groups are introduced at both the 2- and 3-positions can be obtained.

[0064] Examples of compounds for introducing diglycerol groups in this invention include, but are not limited to, the aforementioned 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane.

[0065] There is no particular limitation on the amount of 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane used in this invention, but when a diglycerol group is introduced at the 2- or 3-position, the amount is preferably 0.8 to 1.5 mol, and more preferably 1.0 to 1.2 mol. When a diglycerol group is introduced at both the 2- and 3-positions, the amount is preferably 2.0 to 3.0 mol, and more preferably 2.2 to 2.5 mol.

[0066] The solvents used in the reaction include water, dimethylformamide, dimethyl sulfoxide, N-methylpyrrolidone, tetrahydrofuran, methanol, and ethanol. The reaction temperature is preferably from 20°C to 90°C, and more preferably from 30°C to 80°C.

[0067] When 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxacyclopentane reacts with the hydroxyl group at the 2-position of the ascorbic acid backbone, the pH of the reaction system is alkaline, preferably from pH 8.0 to 12.0, more preferably from pH 9.0 to 11.0. When 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxacyclopentane reacts with the hydroxyl group at the 3-position of the ascorbic acid backbone, the pH of the reaction system is weakly acidic, preferably from pH 3.0 to 6.0, more preferably from pH 3.5 to 5.5.

[0068] The diglycerol group can be introduced by reacting ascorbic acid with 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane, followed by acid treatment. The pH of the acid treatment is preferably 0.5 to 3.0, more preferably 1.0 to 2.0.

[0069] Examples of pH adjusters include lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, malic acid, gluconic acid, sulfuric acid, hydrochloric acid, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, sodium bicarbonate, ammonium bicarbonate, triethylamine, and diazabicycloundecene.

[0070] The solvents used in the acid treatment include water, dimethylformamide, dimethyl sulfoxide, and N-methylpyrrolidone. The reaction temperature is preferably from 0°C to 50°C, and more preferably from 10°C to 40°C.

[0071] Compounds synthesized by the above methods can be purified by column chromatography using silica gel or by crystallization, or by column chromatography using resins (such as ion exchange resins).

[0072] In the ascorbic acid derivatives represented by the above general formula (I) or (II) (where R) 1 R 2 R 4 or R 5 In H), salts can be formed by replacing dissociated hydrogen ions with cations (such as metal ions or ammonium ions), and such salts are also included within the scope of this invention.

[0073] Examples of these salts include inorganic and organic salts. Inorganic salts include alkali metal salts (such as sodium and potassium salts), alkaline earth metal salts (such as calcium and magnesium salts), and ammonium salts. Organic salts include diethanolamine salts, triethanolamine salts, and basic amino acid salts.

[0074] Salts can be formed using methods similar to those used for known salt formation, such as neutralizing R with an alkaline substance. 1 R 2 R 4 or R 5 It is an aqueous solution of an ascorbic acid derivative of H.

[0075] As described above, the synthesized diglycerol-based ascorbic acid can be alkylated, alkenylated, or benzylated using glycidyl, alkyl glycidyl ethers with specific structures, sulfates, alkyl halides, benzyl halides, alkenyl halides, etc., to obtain the ascorbic acid derivative of the present invention represented by general formula (I).

[0076] There are no particular limitations on the amount of alkyl halides, alkenyl halides, benzyl halides, etc. used for alkylation, alkenylation, benzylation, etc., but the amount is preferably 0.8 to 3.0 mol relative to each mole of diglycerol ascorbic acid, and more preferably 1.0 to 2.5 mol.

[0077] Reactions involving alkyl halides, alkenyl halides, and benzyl halides can be carried out using the same solvent, reaction temperature, and pH as those used to introduce the diglycerol group. The ascorbic acid derivatives of the present invention, represented by general formula (I), can be synthesized by purifying these reactions using methods such as column chromatography with silica gel, column chromatography with resins (e.g., ion exchange resins), activated carbon treatment, extraction, distillation, and crystallization.

[0078] The present invention also provides an ascorbic acid derivative composition obtained by combining a conventional ascorbic acid derivative represented by general formula (II) with an ascorbic acid derivative of the present invention, or a salt thereof, represented by general formula (I), in a specific ratio. By combining the ascorbic acid derivative represented by general formula (I) or a salt thereof with the ascorbic acid derivative represented by general formula (II) in a specific ratio, a higher moisturizing effect can be achieved compared with that of conventional ascorbic acid derivatives alone.

[0079] There are no particular limitations on the formulation ratio of the ascorbic acid derivative represented by general formula (I) in the above-mentioned ascorbic acid derivative composition, but it is preferably from 0.1% by mass to 20% by mass. Within this range, a particularly high moisturizing effect can be obtained when incorporated into a cosmetic composition. A high moisturizing effect is difficult to obtain at ratios below 0.1% by mass, and conversely, even if this ratio exceeds 20% by mass, a commensurate effect may not be obtained. The formulation ratio of the ascorbic acid derivative represented by general formula (I) in the above-mentioned composition is more preferably from 5% by mass to 20% by mass, and even more preferably from 10% by mass to 20% by mass.

[0080] Ascorbic acid derivatives represented by general formula (II) can be prepared by the methods described in JP 4681670 B2, but are not limited to these methods.

[0081] The ascorbic acid derivatives or their salts and compositions thereof of the present invention can be applied to a variety of cosmetics, such as topical skin preparations and hair cosmetics. These cosmetics may contain any ingredients commonly used in cosmetics, depending on their intended use, as long as stability and other properties are not compromised.

[0082] Examples of commonly used cosmetic ingredients that can be appropriately mixed include oily components, surfactants and emulsifiers, polymers such as thickeners, whitening agents, texture enhancers, pharmaceuticals, UV absorbers, proteins, protein hydrolysates or their derivatives, amino acids or their derivatives, antioxidants, metal ion chelators, pH adjusters, preservatives, wetting agents, pigments, colorants, and fragrances.

[0083] For oily components, surfactants and emulsifiers, high molecular weight compounds such as thickeners, whitening agents, texture improvers, pharmaceuticals, ultraviolet absorbers, proteins, protein hydrolysates or their derivatives, amino acids or their derivatives, antioxidants, metal ion chelators, pH adjusters, preservatives, wetting agents, pigments, colorants, fragrances, etc., similar examples described in WO2022 / 080287 may be cited.

[0084] The ingredients commonly used in the above cosmetics can be used alone or in combination of two or more.

[0085] The formulation system of the cosmetic composition of the present invention is arbitrary and can be any of the following: solution system, solubilization system, emulsion system, gel system, powder dispersion system, water-oil bilayer system, etc. Depending on the target product, it can be obtained by combining a composition of an ascorbic acid derivative represented by general formula (I) or a salt thereof, or a composition further mixed with an ascorbic acid derivative represented by general formula (II), with any of the above-mentioned components.

[0086] [Example]

[0087] The embodiments for carrying out the present invention will now be described in detail with reference to the examples, but the scope of the invention is not limited to these examples. Prior to the examples, examples of the synthesis of the ascorbic acid derivative of the present invention represented by general formula (I) used in the preparation examples are shown.

[0088] Synthetic Example 1: Synthesis of 2-O-(glycero-O-glycero)ascorbic acid

[0089] In a round-bottom flask, 9.5 ml of deionized water, 8.5 g of ascorbic acid, and 2.2 g of sodium hydroxide were added, and the mixture was heated to 55°C. Then, 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane (10.0 g: 1.1 equivalents of ascorbic acid) was added, and the mixture was stirred for 4.5 hours. After neutralization with 1% hydrochloric acid, the mixture was concentrated under reduced pressure. The resulting residue (21.3 g) was subjected to silica gel chromatography, eluting with a 5 / 1 to 1 / 1 mixture of chloroform and methanol. The mixture was then concentrated under reduced pressure to give 15.0 g of 2-O-(glycero-O-isopropylglyceroylene)ascorbic acid. Then, 44.0 g of 1% hydrochloric acid was added, and the mixture was stirred overnight at room temperature. The solution was then concentrated under reduced pressure, and the resulting residue (18.3 g) was subjected to silica gel chromatography, eluting with a 2 / 1 to 1 / 1 chloroform / methanol mixture. The solution was then concentrated under reduced pressure to give the product (10.2 g).

[0090] The product obtained 1 H-NMR and 13 C-NMR measurements confirmed that it is 2-O-(glycero-O-glycero)ascorbic acid, represented by the following structural formula.

[0091] [Chemical Formula 7]

[0092]

[0093] In addition, in the synthesis examples shown below, the obtained products were subjected to mass spectrometry, 1 H-NMR and 13C-NMR measurements confirmed that each product was an ascorbic acid derivative represented by the structural formula or compound name shown in the respective synthetic examples. Mass spectra of the products obtained in the synthetic examples... 1 H-NMR and 13 The C-NMR measurement results are shown in Tables 1 to 3.

[0094] Synthetic Example 2: Synthesis of 3-O-(glycero-O-glycero)ascorbic acid

[0095] In a round-bottom flask, 2.2 ml of deionized water, 7.0 g of ascorbic acid, and 0.32 g of sodium hydroxide were added, and the mixture was heated to 60°C. Then, 8.3 g of 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane (equivalent to 1.1 times the amount of ascorbic acid) was added, and the mixture was stirred at 70°C for 5 hours. The mixture was then concentrated under reduced pressure. The resulting residue (12.9 g) was subjected to silica gel chromatography, eluting with a 5 / 1 to 1 / 1 mixture of chloroform and methanol. The mixture was then concentrated under reduced pressure to give 9.4 g of 3-O-(glycero-O-isopropylglyceroylene)ascorbic acid. Then, 12.0 g of 1% hydrochloric acid was added, and the mixture was stirred overnight at room temperature. The solution was then concentrated under reduced pressure, and the resulting residue (10.2 g) was subjected to silica gel chromatography, eluted with a 5 / 1 to 2 / 1 mixture of chloroform and methanol. Further concentration under reduced pressure yielded 5.5 g of 3-O-(glycero-O-glycero)ascorbic acid, represented by the following structural formula.

[0096] [Chemical Formula 8]

[0097]

[0098] Synthetic Example 3: Synthesis of 2-O-(glycero-O-glycero)-3-O-ethyl ascorbic acid

[0099] In a round-bottom flask, 1.50 g of 2-O-(glycero-O-glycero)ascorbic acid obtained in Synthesis Example 1, 9.0 ml of DMF, 1.33 g of triethylamine, and diethyl sulfate (1.42 g: 2.0 equivalents relative to 2-O-(glycero-O-glycero)ascorbic acid) were added, and the mixture was stirred at 70°C for 5 hours. The process of adding water and concentrating under reduced pressure was repeated three times, and the resulting residue (2.3 g) was subjected to silica gel chromatography, eluted with a 10 / 1 to 2 / 1 mixture of chloroform and methanol. The mixture was then concentrated under reduced pressure to give 2-O-(glycero-O-glycero)-3-O-ethylascorbic acid (620.5 mg) represented by the structural formula shown below.

[0100] [Chemical Formula 9]

[0101]

[0102] Synthetic Example 4: Synthesis of 2-O-(glycero-O-glycero)-3-O-butylascorbic acid

[0103] In a round-bottom flask, 1.50 g of 2-O-(glycero-O-glycero)ascorbic acid obtained in Synthesis Example 1, 7.5 ml of DMF, 0.33 g of potassium carbonate, and 0.70 g of butyl bromide (1.1 equivalents relative to 2-O-(glycero-O-glycero)ascorbic acid) were added, and the mixture was stirred at 80°C for 4 hours. After cooling and settling, only the supernatant was collected to remove precipitated salts or alkalis. Water was added to the supernatant and the mixture was concentrated under reduced pressure, and this process was repeated three times. The resulting residue (1.86 g) was subjected to silica gel chromatography and eluted with a 10 / 1 to 5 / 1 mixture of chloroform and methanol. Subsequently, the mixture was concentrated under reduced pressure to give 2-O-(glycero-O-glycero)-3-O-butylascorbic acid (630.2 mg) represented by the following structural formula.

[0104] [Chemical Formula 10]

[0105]

[0106] Synthetic Example 5: Synthesis of 2-O-(glycero-O-glycero)-3-O-hexyl ascorbic acid

[0107] 2-O-(glycero-O-glycero)-3-O-hexyl ascorbic acid (601.2 mg) represented by the following structural formula was obtained by the same method as in Synthesis Example 4, except that hexyl bromide (0.84 g) was used instead of butyl bromide.

[0108] [Chemical Formula 11]

[0109]

[0110] Synthetic Example 6: Synthesis of 2-O-(glycero-O-glycero)-3-O-octyl ascorbic acid

[0111] 2-O-(glycero-O-glycero)-3-O-octyl ascorbic acid (637.4 mg) represented by the following structural formula was obtained by the same method as in Synthesis Example 4, except that octyl bromide (1.0 g) was used instead of butyl bromide.

[0112] [Chemical Formula 12]

[0113]

[0114] Synthetic Example 7: Synthesis of 2-O-(glycero-O-glycero)-3-O-tetradecyl ascorbic acid

[0115] 2-O-(glycero-O-glycero)-3-O-tetradecyl ascorbic acid (521.2 mg) represented by the following structural formula was obtained by the same method as in Synthesis Example 4, except that butyl bromide (1.41 g) was used instead of tetradecyl bromide.

[0116] [Chemical Formula 13]

[0117]

[0118] Synthetic Example 8: Synthesis of 2-O-(glycero-O-glycero)-3-O-hexadecyl ascorbic acid

[0119] 2-O-(glycero-O-glycero)-3-O-hexadecyl ascorbic acid (804.3 mg) represented by the following structural formula was obtained by the same method as in Synthesis Example 4, except that butyl bromide (1.04 g) was used instead of hexadecyl bromide.

[0120] [Chemical Formula 14]

[0121]

[0122] Synthetic Example 9: Synthesis of 2-O-(glycero-O-glycero)-3-O-glyceroascorbic acid

[0123] First, 3-O-glyceroascorbic acid was synthesized by the method and conditions described in Example 1 of JP 4681670 B2.

[0124] Next, 1.8 g of 3-O-glyceroascorbic acid, 1.0 ml of deionized water, 0.06 g of sodium bicarbonate, and 1.5 g of 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane (equivalent to 1.1 times the amount of 3-O-glyceroascorbic acid) were added to a round-bottom flask, and the mixture was stirred at 60°C for 5 hours. The mixture was then concentrated under reduced pressure. The resulting residue (2.20 g) was subjected to silica gel chromatography, eluted with a 5 / 1 chloroform / methanol mixture, and concentrated under reduced pressure to give 530.7 mg of 2-O-(glycero-O-isopropylglycero)-3-O-glyceroascorbic acid. Then, 2.0 g of 1% hydrochloric acid was added, and the mixture was stirred overnight at room temperature. After neutralization with a 1% aqueous sodium hydroxide solution, the mixture was concentrated under reduced pressure. The resulting residue (660.3 mg) was subjected to silica gel chromatography and eluted with a 5 / 1 to 2 / 1 mixture of chloroform and methanol. Subsequently, it was concentrated under reduced pressure to give 316.5 mg of 2-O-(glycero-O-glycero)-3-O-glyceroascorbic acid represented by the following structural formula.

[0125] [Chemical Formula 15]

[0126]

[0127] Synthetic Example 10: Synthesis of 2-O-ethyl-3-O-(glycero-O-glycero)ascorbic acid

[0128] In a round-bottom flask, 1.0 g of 3-O-(glycero-O-glycero)ascorbic acid obtained in Synthesis Example 2, 5.0 ml of DMF, 0.65 g of potassium carbonate, and diethyl sulfate (0.93 g: 2.0 equivalents relative to 3-O-(glycero-O-glycero)ascorbic acid) were added, and the mixture was stirred at 70°C for 3 hours. After cooling and settling, only the supernatant was collected to remove precipitated salts or alkalis. Water was added to the supernatant and the mixture was concentrated under reduced pressure, and this process was repeated three times. The resulting residue (1.34 g) was subjected to silica gel chromatography and eluted with a 10 / 1 to 2 / 1 mixture of chloroform and methanol. Subsequently, the mixture was concentrated under reduced pressure to give 696.2 mg of 2-O-ethyl-3-O-(glycero-O-glycero)ascorbic acid represented by the following structural formula.

[0129] [Chemical Formula 16]

[0130]

[0131] Synthetic Example 11: Synthesis of 2-O-butyl-3-O-(glycero-O-glycero)ascorbic acid

[0132] In a round-bottom flask, 1.0 g of 3-O-(glycero-O-glycero)ascorbic acid obtained in Synthesis Example 2, 5.0 ml of DMF, 0.17 g of sodium carbonate, and 0.45 g of butyl bromide (1.1 equivalents of 3-O-(glycero-O-glycero)ascorbic acid) were added, and the mixture was stirred overnight at 50°C. After neutralization with 1% hydrochloric acid, the supernatant was diluted with water and concentrated under reduced pressure. This process was repeated three times. The resulting residue (1.93 g) was subjected to silica gel chromatography and eluted with a 10 / 1 to 5 / 1 mixture of chloroform and methanol. Subsequently, the mixture was concentrated under reduced pressure to give 462.6 mg of 2-O-butyl-3-O-(glycero-O-glycero)ascorbic acid represented by the following structural formula.

[0133] [Chemical Formula 17]

[0134]

[0135] Synthetic Example 12: Synthesis of 2-O-hexyl-3-O-(glycero-O-glycero)ascorbic acid

[0136] 2-O-hexyl-3-O-(glycero-O-glycero)ascorbic acid (423.1 mg) represented by the following structural formula was obtained by the same method as in Synthetic Example 11, except that hexyl bromide (0.55 g) was used instead of butyl bromide.

[0137] [Chemical Formula 18]

[0138]

[0139] Synthetic Example 13: Synthesis of 2-O-octyl-3-O-(glycero-O-glycero)ascorbic acid

[0140] 2-O-octyl-3-O-(glycero-O-glycero)ascorbic acid (437.6 mg) represented by the following structural formula was obtained by the same method as in Synthetic Example 11, except that octyl bromide (0.64 g) was used instead of butyl bromide.

[0141] [Chemical Formula 19]

[0142]

[0143] Synthetic Example 14: Synthesis of 2-O-tetradecyl-3-O-(glycero-O-glycero)ascorbic acid

[0144] 2-O-tetradecyl-3-O-(glycero-O-glycero)ascorbic acid (310.2 mg) represented by the following structural formula was obtained by the same method as in Synthesis Example 11, except that tetradecyl bromide (0.92 g) was used instead of butyl bromide.

[0145] [Chemical Formula 20]

[0146]

[0147] Synthetic Example 15: Synthesis of 2-O-glycero-3-O-(glycero-O-glycero)ascorbic acid

[0148] First, 2-O-glyceroascorbic acid was synthesized by the method described in Example 3 of JP 4681670 B2.

[0149] Next, 2.5 g of 2-O-glyceroascorbic acid, 0.8 ml of deionized water, and 0.12 g of sodium hydroxide were added to a round-bottom flask and heated to 60°C. Then, 4-[(2,3-epoxypropoxy)methyl]-2,2-dimethyl-1,3-dioxane (2.1 g: 1.1 equivalents relative to 2-O-glyceroascorbic acid) was added, and the mixture was stirred at 72°C for 5 hours. The mixture was then concentrated under reduced pressure, and the resulting residue (4.28 g) was subjected to silica gel chromatography, eluting with a 5 / 1 to 1 / 1 mixture of chloroform and methanol. The mixture was then concentrated under reduced pressure to give 2-O-glycero-3-O-(glycero-O-isopropylglycerylene)ascorbic acid (1.89 g). Then, 5.78 g of 1% hydrochloric acid was added, and the mixture was stirred overnight at room temperature. After neutralization with a 1% sodium hydroxide aqueous solution, the solution was concentrated under reduced pressure. The resulting residue (2.01 g) was subjected to silica gel chromatography and eluted with a 5 / 1 to 2 / 1 mixture of chloroform and methanol. Subsequently, the solution was concentrated under reduced pressure to give 1.42 g of 2-O-glycero-3-O-(glycero-O-glycero)ascorbic acid represented by the following structural formula.

[0150] [Chemical Formula 21]

[0151]

[0152] The products obtained in Synthetic Examples 1 to 15 were subjected to mass spectrometry using an LC-MS-2020 (manufactured by Shimadzu Corporation). The measurement results are shown in Table 1.

[0153] [Table 1]

[0154]

[0155] *Ionization was performed using electrospray ionization (ESI).

[0156] The products obtained in Synthetic Examples 1 to 15 were subjected to JNM-ECS400 (manufactured by JEOL Ltd.) 1 H-NMR. The measurement results are shown in Table 2.

[0157] [Table 2]

[0158]

[0159]

[0160] The products obtained in Synthetic Examples 1 to 15 were subjected to JNM-ECS400 (manufactured by JEOL Ltd.) 13 C-NMR. The measurement results are shown in Table 3.

[0161] [Table 3]

[0162]

[0163]

[0164] Experimental Example 1 [Moisturizing Test: Measurement of Moisturizing Effect Based on Water Retention Capacity]

[0165] Vacuum-dry each sample listed in Table 4 below, and distribute approximately 400 mg (this weight is denoted as W0) of each sample into weighing bottles (1.7 cm in diameter and 4.0 cm in height without the cap). Place each sample in the weighing bottle in a constant temperature and humidity chamber (LTI-1200, manufactured by Tokyo Rikakikai Co., Ltd.) at 25°C and 75% humidity. Measure the weight periodically and allow the samples to stand until they have absorbed sufficient moisture and the weight no longer changes. Then, transfer the samples to a sealed container filled with a saturated potassium acetate aqueous solution at 25°C and 35% humidity, and calculate the amount of moisture W retained per gram of dried sample using the following formula from the weight after 7 days (this weight is denoted as W1). h (mg / g).

[0166] W h = (W1- W0) / W0

[0167] The moisturizing effect is calculated using the water retention capacity W in this way. h The criteria were determined based on the following standards, and the results are shown in Table 4.

[0168] (Judgment criteria)

[0169] ◎: 60mg / g or more

[0170] 〇: 45 mg / g or higher but less than 60 mg / g

[0171] △: 20 mg / g or higher but less than 45 mg / g

[0172] ×: Less than 10 mg / g

[0173] [Table 4]

[0174]

[0175] The results in Table 4 show that the ascorbic acid derivatives or salts of the present invention retain a greater amount of water per gram of sample compared to conventional ascorbic acid derivatives with glycerol groups. In particular, Examples 1 and 2 retain approximately twice the amount of water, demonstrating excellent water retention capabilities.

[0176] Experimental Example 2 [Moisturizing Test: Measurement of Moisturizing Effect in a Closed Environment]

[0177] Cover a weighing bottle (7 mm in diameter, 3.2 cm high without the cap) containing 200 mg of deionized water with cellulose filter paper (8 mm in diameter, 0.19 mm thick). Prepare the following samples as 1.5 mmol / g aqueous solutions, and spread 5 μl of each solution thinly and evenly onto the cellulose filter paper. Store the weighing bottle in a constant temperature bath at 60°C for 5 hours. Measure the weight (mg) and use the amount of water lost (this weight is referred to as W). d Calculate the residual moisture percentage (X%) in the weighing bottle using the following formula.

[0178] X = 100 - (W d / 200 × 100)

[0179] As a control experiment, 5 μL of deionized water was used to determine the residual rate, which was found to be 70.5%. The difference between the residual rate of the sample and the residual rate of the control sample was calculated using the following formula (this difference is denoted as d (%)).

[0180] d = X - 70.5

[0181] Based on the results calculated in this way, the moisturizing effect was determined according to the following criteria, and the results are shown in Table 5.

[0182] (Judgment criteria)

[0183] ◎:More than 15.0%

[0184] 〇: 10.0% or higher but less than 15.0%

[0185] △: 5.0% or higher but less than 10.0%

[0186] ×: Below 5.0%

[0187] [Table 5]

[0188]

[0189] The results in Table 5 clearly demonstrate that the ascorbic acid derivatives or salts of the present invention have superior moisturizing effects compared to conventional ascorbic acid derivatives or salts with glycerol groups.

[0190] Experimental Example 3 [Moisturizing Experiment 2: Measurement of Moisturizing Effect by Water Retention Capacity 2]

[0191] For the compositions in the proportions shown in Examples 12-19 and Comparative Examples 12 and 13 in Tables 6 and 7 below, the amount of water W retained per gram of dried sample was calculated using the method described in Test Example 1. h (mg / g). The moisturizing effect was then determined based on the following criteria, and the results are shown in Tables 6 and 7.

[0192] (Judgment criteria)

[0193] ◎: 75 mg or more

[0194] 〇: 55 mg or more but less than 75 mg

[0195] △: 35 mg or more but less than 55 mg

[0196] ×: Less than 35 mg

[0197] [Table 6]

[0198]

[0199] [Table 7]

[0200]

[0201] The results in Tables 6 and 7 clearly demonstrate that adding a small amount of ascorbic acid derivative containing diglycerides to conventional ascorbic acid derivatives containing glycerides significantly improves the moisturizing effect of the ascorbic acid derivatives containing glycerides.

[0202] Example 20: Toner (lotion)

[0203] The lotion was prepared by mixing the ingredients (1) to (6) shown in Table 8 while stirring thoroughly. In the subsequent tables of Table 8, the quantities are expressed in parts by mass.

[0204] [Table 8]

[0205]

[0206] *1: This refers to the amount required to make a total of 100 parts by mass. This also applies to the following tables.

[0207] Example 21: Emulsion

[0208] The raw materials (1) to (9) of the oil phase and the raw materials (10) to (13) of the aqueous phase shown in Table 9 were heated to 70°C and dissolved to prepare the oil phase and the aqueous phase, respectively. Then, the oil phase was added to the aqueous phase and pre-emulsified, and after homogenization using a homogenizer, the emulsion was prepared by cooling to room temperature while stirring thoroughly.

[0209] [Table 9]

[0210]

[0211] Example 22: Cream

[0212] The raw materials (1) to (5) of the oil phase and the raw materials (6) to (10) of the aqueous phase shown in Table 10 were heated to 70°C and dissolved to prepare the oil phase and the aqueous phase, respectively. Then, the oil phase was added to the aqueous phase and pre-emulsified, and after homogenization using a homogenizer, the mixture was cooled to room temperature while being thoroughly stirred to prepare a cream.

[0213] [Table 10]

[0214]

Claims

1. An ascorbic acid derivative or a salt thereof, characterized in that... Represented by the following general formula (I), [Chemical Formula 1] In equation (I), R 1 and R 2 H, alkyl groups having 1 to 22 carbon atoms, alkenyl groups having 2 to 22 carbon atoms, benzyl groups, R 3 -CH(CH2OH)-、R 3 -CH(OH)-CH2-、R 3 -O-CH2-CH(OH)-CH2- or R 3 -O-CH2-CH(CH2OH)-, where R 3 It is H, an alkyl group having 1 to 22 carbon atoms, or CH2OH-CH(OH)-CH2-, but R 1 and R 2 At least one of them is CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-.

2. The ascorbic acid derivative or its salt according to claim 1, characterized in that, R 1 and R 2 One of them is CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-, while the other is H, an alkyl group having 4 to 18 carbon atoms, CH2(OH)-CH(OH)-CH2-, CH2OH-CH(CH2OH)-, CH2OH-CH(OH)-CH2-O-CH2-CH(OH)-CH2- or CH2OH-CH(OH)-CH2-O-CH2-CH(CH2OH)-.

3. An ascorbic acid derivative composition comprising an ascorbic acid derivative or a salt thereof represented by general formula (I) and an ascorbic acid derivative or a salt thereof represented by general formula (II), wherein the content of the ascorbic acid derivative or a salt thereof represented by general formula (I) is from 0.1% by mass to 20% by mass of the total amount of the ascorbic acid derivative or a salt thereof represented by general formula (I) and the ascorbic acid derivative or a salt thereof represented by general formula (II). [Chemical Formula 2] In equation (II), R 4 Or R 5 Any one of them is R 6 -O-CH2-CH(OH)-CH2-、R 6 -O-CH2-CH(CH2OH)-、R 6 -CH(CH2OH)- or R 6 -CH(OH)-CH2-, while the other is H, alkyl with 1 to 22 carbon atoms, alkenyl with 2 to 22 carbon atoms, benzyl, R 6 -O-CH2-CH(OH)-CH2-、R 6 -O-CH2-CH(CH2OH)-、R 6 -CH(CH2OH)- or R 6 -CH(OH)-CH2-, where R 6 (H, alkyl group having 1 to 22 carbon atoms, alkenyl group or phenyl group having 2 to 22 carbon atoms).

4. A cosmetic product, characterized in that it is formulated with an ascorbic acid derivative or a salt thereof according to claim 1 or claim 2, or an ascorbic acid derivative composition according to claim 3.

Citation Information

Patent Citations

  • Ascorbic acid derivative, production thereof and antioxidant comprising said derivative

    JP1989228978A

  • Ascorbic acid derivatives or salts thereof, methods for producing the same, and cosmetics

    JP4681670B2

  • Ascorbic acid derivatives or their salts and cosmetics containing them

    JP7267657B1

  • Collagen production promoter, and skin cosmetic containing said collagen production promoter

    WO2022080287A1